ScienceDex / Researcher record
Arnold, Katelyn
- Glycan Therapeutics Corporation (no department on record)
- Glyco Discoveries, Inc (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #29,139
- Early Career
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2021 | $231,139 | 1 | #35,607 |
| 2023 | $400,000 | 2 | #29,139 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20211 record
- FY2023 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Arnold, Katelyn as a PI. Multi-PI records show the full award amount for context.
- 1R41CA285005-01R41Contact PIDevelopment ofsynthetic heparin to protect liver graft from ischemia reperfusion injury duringtransplantation$251.1Kaward amount
- 6R41CA285005-02R41Contact PIDevelopment ofsynthetic heparin to protect liver graft from ischemia reperfusion injury duringtransplantation$148.9Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Arnold, Katelyn as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardGlycan Therapeutics Corporation
- 2023$500K Cumulative Funding
- 2023Multi-Institutional ResearchAwards at 2 institutions